BioXcel Therapeutics Inc (NASDAQ:BTAI)

Delayed Data
As of Jun 30
 -0.16 / -1.20%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 52.00, with a high estimate of 110.00 and a low estimate of 10.00. The median estimate represents a +293.34% increase from the last price of 13.22.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in BioXcel Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.58%
Growthannually -15.62%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.